Skip to main content

Faktor VIII: Biochemie und Physiologie

  • Chapter
  • 27 Accesses

Zusammenfassung

Faktor VIII (FVIII) ist ein Glykoprotein, das nur in Spurenkonzentrationen im Humanplasma vorkommt. Als Kofaktor von Faktor IXa (F IXa) ist FVIII für die Aktivierung von Faktor X (FX) essentiell. Mangel und Defekte dieses Proteins kennzeichnen das Bild der klassischen Hämophilie A, die bereits vor 1700 Jahren im Talmud beschrieben wurde. Im Blut zirkuliert der FVIII als Komplex mit dem Von-Willebrand-Faktor (VWF), der zur primären Hämostase beiträgt. Zwischen beiden Faktoren bestehen vielfältige Wechselwirkungen von physiologischer Bedeutung. Die Molekularstruktur des F VIII wurde durch die Klonierung der F VIII-cDNA bekannt.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Antonarakis SE, Kazazian HH, Tuddenham EG (1995) Molecular etiology of factor VIII deficiency in hemophilia A. Human Mutation 5:1–22

    Article  PubMed  CAS  Google Scholar 

  • Brinkhous KM, Sandberg H, Garris JB et al. (1985) Purified human factor VIII procoagulant protein: comparative he-mostatis response after infusion into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci USA 82:8752–8756

    Article  PubMed  CAS  Google Scholar 

  • Eaton D, Rodriguez H, Vehar GA (1986) Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. Biochemistry 25:505–512

    Article  PubMed  CAS  Google Scholar 

  • Eaton DL, Wood WI, Eaton D et al. (1987) Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule. Biochemistry 25:8342–8347

    Google Scholar 

  • Fay PJ (1987) Subunit structure of thrombin-activated human factor Villa. Biochim Biophys Acta 952:181–190

    Article  Google Scholar 

  • Fay PJ, Anderson MT, Chavin SI, Marder VJ (1986) The size of human factor VIII heterodimers and the effects produced by thrombin. Biochim Biophys Acta 871:268–278

    Article  PubMed  CAS  Google Scholar 

  • Fay PJ, Haidaris PJ, Smudzin TM (1991) Human factor Villa subunit structure. J Biol Chem 266:8957–8962

    PubMed  CAS  Google Scholar 

  • Fulcher CA, Zimmerman TS (1982) Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody. Proc Natl Acad Sci USA 79:1648–1652

    Article  PubMed  CAS  Google Scholar 

  • Heimburger N, Schwinn H, Gratz P et al. (1981) Faktor VIII-Konzentrat, hochgereinigt und in Lösung erhitzt. Arzneimittelforschung 31:619–622

    PubMed  CAS  Google Scholar 

  • Kaufman RJ (1992) Biological regulation of factor VIII activity. Annu Rev Med 43:325–339

    Article  PubMed  CAS  Google Scholar 

  • Kaufman RJ, Antonarakis SE (1995) Structure, biology, and genetics of factor VIII. In: Hoffman R et al. (eds) Hematology: basic principles and practice, 2nd edn. Churchill Livingstone, Edinburgh, Scotland, pp 1633–1648

    Google Scholar 

  • Lollar P, Parker CG (1989) Subunit structure of thrombin-activated porcine factor VIII. Biochemistry 28:666–674

    Article  PubMed  CAS  Google Scholar 

  • Marder VJ, Mannucci PM, Firkin BG et al. (1985) Standard nomenclature for factor VIII and von Willebrand factor: a recommendation by the International Committee on Thrombosis and Haemostasis. Thromb Haemost 54:871–872

    PubMed  CAS  Google Scholar 

  • Nesheim M, Pittman DD, Giles AR et al. (1991) The effect of von Willebrand factor on the binding of factor VIII to thrombin activated platelets. J Biol Chem 266:17815–17820

    PubMed  CAS  Google Scholar 

  • Pittman DD, Kaufman RJ (1988) Proteolytic requirements for thrombin activation of antihemophilic factor (factor VIII). Proc Natl Acad Sci USA 85:2429–2433

    Article  PubMed  CAS  Google Scholar 

  • Pittman DD, Millenson M, Marquette K et al. (1992) A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage. Blood 79:389–397

    PubMed  CAS  Google Scholar 

  • Schimpf K, Mannucci PM, Kreutz W et al. (1987) Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions. N Engl J Med 316:918–922

    Article  PubMed  CAS  Google Scholar 

  • Wacey AI, Kemball-Cook G, Kazazian HH et al. (1996) The haemophilia A mutation search test and resource site, home page of the factor VIII mutation database: HAM-STeRS. Nucl.Acids Res 24:100–102

    Article  PubMed  CAS  Google Scholar 

  • Wion KL, Kelly D, Summerfield JA et al. (1985) Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 317:726–729

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Heimburger, N. (1999). Faktor VIII: Biochemie und Physiologie. In: Müller-Berghaus, G., Pötzsch, B. (eds) Hämostaseologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07673-6_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-07673-6_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-07674-3

  • Online ISBN: 978-3-662-07673-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics